Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Petrucci

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Blood|June 15, 1993
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cellsH Hata, H Xiao, M T Petrucci, et al.
Current Hematologic Malignancy Reports|May 12, 2019
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple MyelomaM Offidani, M Boccadoro, F Di Raimondo, et al.
Muscle & Nerve|November 18, 2008
Dissociation between cutaneous silent period and laser evoked potentials in assessing neuropathic painA Truini, F Galeotti, A Biasiotta, et al.
Haematologica|May 1, 1989
Treatment of recurrent promyelocytic leukemia with a combination regimen utilizing amsacrine, cytosine arabinoside and 6-thioguanine (AAT)G Avvisati, M C Petti, M T Petrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 14, 2000
Isolated granulocytic sarcoma of the skin in an elderly patient: good response to treatment with local radiotherapy and low-dose methotrexateA Pulsoni, P Falcucci, G Anghel, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killingA Tafuri, L De Felice, M G Mascolo, et al.
Leukemia & Lymphoma|July 1, 1993
Coexistent multiple myeloma and myelofibrosisA Pulsoni, P Bianco, G La Verde, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseasesG De Rossi, G De Sanctis, V Bottari, et al.
Leukemia|June 21, 2013
Review of health-related quality of life data in multiple myeloma patients treated with novel agentsP Sonneveld, S G Verelst, P Lewis, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaG Cimino, G Avvisati, S Amadori, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Blood|June 15, 1993
Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cellsH Hata, H Xiao, M T Petrucci, et al.
Current Hematologic Malignancy Reports|May 12, 2019
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple MyelomaM Offidani, M Boccadoro, F Di Raimondo, et al.
Muscle & Nerve|November 18, 2008
Dissociation between cutaneous silent period and laser evoked potentials in assessing neuropathic painA Truini, F Galeotti, A Biasiotta, et al.
Haematologica|May 1, 1989
Treatment of recurrent promyelocytic leukemia with a combination regimen utilizing amsacrine, cytosine arabinoside and 6-thioguanine (AAT)G Avvisati, M C Petti, M T Petrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 14, 2000
Isolated granulocytic sarcoma of the skin in an elderly patient: good response to treatment with local radiotherapy and low-dose methotrexateA Pulsoni, P Falcucci, G Anghel, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killingA Tafuri, L De Felice, M G Mascolo, et al.
Leukemia & Lymphoma|July 1, 1993
Coexistent multiple myeloma and myelofibrosisA Pulsoni, P Bianco, G La Verde, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseasesG De Rossi, G De Sanctis, V Bottari, et al.
Leukemia|June 21, 2013
Review of health-related quality of life data in multiple myeloma patients treated with novel agentsP Sonneveld, S G Verelst, P Lewis, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaG Cimino, G Avvisati, S Amadori, et al.
Pageof 6